Optimal Systemic Treatment and Real-World Clinical Application of ctDNA in Patients With Metastatic HER2-Mutant NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancer
Eur. J. Cancer 2024 Aug 14;210(xx)114257, SY Liu, T Erazo, J Jee, A Arfe, A Gupta, LRG Pike, FC Santini, B Daly, A Schoenfeld, J Eichholz, K Johnson, A Martinez, J Sui, N Riaz, J Chang, SR Yang, W Travis, ME Arcila, J Guo, E Gagne, K Garg, F Baehner, NY Lee, A Drilon, MG Kris, HI Scher, P Razavi, DR Gomez, DR Jones, CM Rudin, S Chandarlapaty, JM Isbell, BT LiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.